ELEA MARTINEZ: Open Payments
NPI 1558785626 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,236 in 45 payments from 14 companies in 2025. Trend: 2023 $767 · 2024 $804 · 2025 $1,236
Food & beverage: $1,143Education: $93
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $284 |
| Regeneron Healthcare Solutions, Inc. | 9 | $250 |
| Genentech USA, Inc. | 4 | $116 |
| Novartis Pharmaceuticals Corporation | 3 | $103 |
| GENZYME CORPORATION | 3 | $77 |
| GlaxoSmithKline, LLC. | 3 | $72 |
| Pharming Healthcare, Inc. | 1 | $65 |
| Incyte Corporation | 2 | $51 |
| Amgen Inc. | 2 | $51 |
| Viatris Specialty LLC | 2 | $46 |
Products named: DUPIXENT, Xolair, BREZTRI, FASENRA, NUCALA, Rhapsido, RUCONEST, TEZSPIRE.
Industry payments across NM — which companies pay providers there.
